image a? la une - autorisation fleurs New York comp

Cannabis flower allowed in New York's medical cannabis program

On 5 October, the New York State Cannabis Control Board (CCB) met to vote to include the sale of flowers, previously prohibited, in the medical cannabis programme. Other items discussed included increasing the limit on cannabis purchases from 30 to 60 days; allowing physicians licensed to prescribe controlled substances to certify a medical cannabis patient; and permanently waiving the $50 registration fee for patients and caregivers. This meeting and the decisions that followed mark the beginning of the first regulations for the establishment of the future adult-use cannabis industry in New York.

The issue of self-cultivation still pending...

As a reminder, the former governor of New York State, Andrew Cuomo, signed the Marijuana Regulation and Taxation Act (MRTA) on 31 March. He had been trying for years to negotiate with the authors of the bill in vain and had even set up a task force. Finally, cannabis for adult use was legalized and the existing medical cannabis and hemp programs were expanded. However, the CCB was late in addressing the issue of self-cultivation for patients, so it was not on the agenda. Tremaine Wright, head of the BAC, was aware that he had missed the first deadline, but was determined to draft the regulations on the subject and put them out for public comment. They will be on the agenda for future meetings in the near future.

Positive impact on the medical cannabis programme?

On the other hand, the Executive Director of the Office of Cannabis Managment, Chris Alexander, welcomes the news of the approval of whole flower. He is confident that this will increase patient uptake, due to the reduced cost of the product. issue of self-cultivation still pending... As a reminder, the former governor of New York State, Andrew Cuomo, signed the Marijuana Regulation and Taxation Act (MRTA) on 31 March last. He had been trying for years to negotiate with the authors of the bill in vain and had even set up a task force. Finally, cannabis for adult use was legalized and the existing medical cannabis and hemp programs were expanded. However, the CCB was late in addressing the issue of self-cultivation for patients, so it was not on the agenda. Tremaine Wright, head of the BAC, was aware that he had missed the first deadline, but was determined to draft the regulations on the subject and put them out for public comment. They will be on the agenda for future meetings in the near future. Positive impact on the medical cannabis programme? On the other hand, the Executive Director of the Office of Cannabis Managment, Chris Alexander, welcomes the news of the approval of whole flower. He is confident that this will increase patient uptake, due to the reduced cost of the product.

Product successfully added to your shopping cart
Quantity
Continue shopping
My cart
There are 0 items in your cart. There is 1 item in your cart.
Total products :